Effient Shows Consistent Safety Irrespective of Aspirin Dosage

Tuesday, October 22nd, 2013

New data released from the TRITON-TIMI 38 study suggests that the efficacy and safety of prasugrel (Effient) remains consistent irrespective of the dose of aspirin. The researchers associated with the study also found that the medication had no significant interaction with aspirin. Patients that were given prasugrel post ACS had lower rates of mortality, stroke, […]

Effient Offers Little Benefit in Dual Antiplatelet Pretreatment

Sunday, September 22nd, 2013

Non-ST-segment-elevation acute myocardial infarction (NSTEMI) treatment guidelines current recommend dual antiplatelet treatment to begin as early as possible. However, it has been unclear whether early treatment offers any significant benefits, especially with new and more potent antiplatelet agents like prasugrel (Effient). Now, a new study called ACCOAST recently showed strong evidence that pretreatment with prasugrel […]